Quintiles IMS Holdings Inc. reported a net loss of $178 million in the fourth quarter of 2016, but its adjusted earnings per share beat analysts’ expectations.

The company reported an adjusted diluted earnings per share of $1.09 in the fourth quarter of 2016, which beat analysts’ expectations of $1.06.

The Durham-based health information services and clinical research company reported its first earnings after its merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings Inc., which was completed in October.

Its net loss of $178 million in the fourth quarter was primarily due to a one-time deferred tax charge from a reinvestment of foreign earnings, according to a securities filing. Last year, the company returned a profit of $105 million in the fourth quarter.

Quintiles IMS Holdings revenue grew to $1.953 billion in the fourth quarter of 2016 from $1.129 billion in the fourth quarter of 2015, an increase of 73.1 percent on a reported basis.

The legacy IMS commercial business had revenues of $860 million in the fourth quarter of 2016 and grew 6.9 percent from 2015 on a constant currency basis. The legacy Quintiles commercial business had revenues of $74 million and declined 14 percent at constant currency basis during the same time period.

“For our first quarter as a combined company, we delivered a strong operational performance and achieved financial results in line with or above our targets,” said Ari Bousbib, chairman and CEO, in a statement. “The post-merger integration process is advancing well and we are pleased with our progress to date.”

QuintilesIMS has approximately 50,000 employees that conduct operations in more than 100 countries.

The company’s stock is traded on the New York Stock Exchange under the ticker Q. Its stock was trading at $82.85 on Tuesday afternoon, up 3.56 percent from Monday’s close.